Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
631.00    -3.00 (-0.47%)
Bid:
631.00
Ask:
634.00
Spread: 3.00 (0.475%)
Market Cap: £510.12m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Holding(s) in Company

4 Sep 2012 17:41

RNS Number : 4978L
Bloomsbury Publishing PLC
04 September 2012
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Bloomsbury Publishing PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

LIONTRUST INVESTMENT PARTNERS LLP

4. Full name of shareholder(s)  (if different from 3.):iv

N/A

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

03/09/2012

6. Date on which issuer notified:

04/09/2012

7. Threshold(s) that is/are crossed orreached: vi, vii

10 %

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

 

GB0033147751

6,967,014

6,967,014

7,412,884

7,412,884

N/A

10.03 %

N/A

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

N/A

N/A

N/A

N/A

N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

N/A

N/A

N/A

N/A

N/A

Nominal

Delta

N/A

N/A

Total (A+B+C)

Number of voting rights

Percentage of voting rights

7,412,884

10.03 %

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

N/A

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

14. Contact name:

Michael Daykin

Group Company Secretary,Bloomsbury Publishing Plc

15. Contact telephone number:

0207 631 5627

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUSONRUKAKRAR
Date   Source Headline
21st Apr 20208:45 amRNSTotal Voting Rights
20th Apr 202012:02 pmRNSPrice Monitoring Extension
17th Apr 202011:50 amRNSResult of Placing
17th Apr 20207:00 amRNSTrading and Dividend Update & Equity Placing
16th Apr 20204:41 pmRNSSecond Price Monitoring Extn
16th Apr 20204:35 pmRNSPrice Monitoring Extension
30th Mar 20204:42 pmRNSSecond Price Monitoring Extn
30th Mar 20204:36 pmRNSPrice Monitoring Extension
20th Mar 20207:00 amRNSBloomsbury Acquires Zed Books' Assets
19th Mar 20207:00 amRNSPre-close Trading Update
5th Feb 20205:39 pmRNSDirector Declaration
10th Dec 201910:45 amRNSBloomsbury Acquires Oberon Books
2nd Dec 20197:00 amRNSBLOOMSBURY ENTERS DOMESTIC CHINESE MARKET
25th Nov 20195:15 pmRNSBlock Listing Six Monthly Return
29th Oct 20197:00 amRNSUnaudited Interim Results
21st Oct 20196:18 pmRNSHolding(s) in Company
16th Oct 20195:58 pmRNSHolding(s) in Company
12th Sep 20195:29 pmRNSHolding(s) in Company
5th Sep 20193:37 pmRNSHolding(s) in Company
22nd Aug 20197:00 amRNSDirector/PDMR Shareholding
17th Jul 20194:19 pmRNSResults of the 2019 Annual General Meeting
17th Jul 20197:00 amRNSTrading Update
18th Jun 20198:21 amRNSAnnual Financial Report
7th Jun 201911:34 amRNSHolding(s) in Company
7th Jun 20197:00 amRNSHolding(s) in Company
31st May 20193:11 pmRNSDirector/PDMR Shareholding
24th May 20193:21 pmRNSBlock listing Interim Review
23rd May 201912:30 pmRNSDirector/PDMR Shareholding
22nd May 20198:09 amRNSDividend Declaration
21st May 201912:47 pmRNSBoard Appointment
21st May 20197:00 amRNSAudited Preliminary Results
14th May 20193:19 pmRNSDirector/PDMR Shareholding
2nd May 20191:30 pmRNSHolding(s) in Company
4th Apr 20194:28 pmRNSHolding(s) in Company
19th Mar 20197:00 amRNSBloomsbury Publishing Plc - Trading Update
7th Jan 20197:00 amRNSBloomsbury Announces Two Digital Partnerships
6th Dec 20184:40 pmRNSSecond Price Monitoring Extn
6th Dec 20184:35 pmRNSPrice Monitoring Extension
20th Nov 20183:36 pmRNSBlock Listing Six Monthly Return
8th Nov 20189:00 amRNSBloomsbury's Sarah J. Maas tops bestseller lists
23rd Oct 20187:05 amRNSICAEW partners with Bloomsbury Professional
23rd Oct 20187:00 amRNSBloomsbury Interim Results
19th Sep 20187:00 amRNSBloomsbury to publish Authorised History of GCHQ
18th Sep 20185:29 pmRNSDirector/PDMR Shareholding
31st Jul 20185:25 pmRNSDirector/PDMR Shareholding
18th Jul 20183:00 pmRNSResult of AGM
18th Jul 20187:01 amRNSBloomsbury Partnership with YOOX NET-A-PORTER
18th Jul 20187:00 amRNSTrading Update
9th Jul 20187:00 amRNSBloomsbury Author Wins The Golden Man Booker Prize
6th Jul 20186:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.